| 标题 |
Ramucirumab versus placebo in combination with second-line FOLFIRI in patients with metastatic colorectal carcinoma that progressed during or after first-line therapy with bevacizumab, oxaliplatin, and a fluoropyrimidine (RAISE): a randomised, double-blind, multicentre, phase 3 study |
| 网址 | |
| DOI | |
| 其它 |
期刊:The Lancet. Oncology 作者:Tabernero J; Yoshino T; Cohn AL; Obermannova R; Bodoky G; et al 出版日期:2015/05/01 |
| 求助人 | |
| 下载 | 求助已完成,仅限求助人下载。 |
PDF的下载单位、IP信息已删除
(2025-6-4)